The clinical data are sparse for hypertension, cholesterol levels and CRP, but one experimental study has demonstrated that GDF8 deletion in a mouse model of metabolic syndrome resulted in increased muscle mass and prevented an increase in blood pressure [21]. The gene discussed is MSTN; the disease is metabolic syndrome.